| Sreelatha Mandadi, SLP | |
|
5100 Marna Lynn Ave Nw, Albuquerque, NM 87114-5701 | |
| (505) 898-0923 | |
| Not Available |
| Full Name | Sreelatha Mandadi |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 5100 Marna Lynn Ave Nw, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114201530 | NPI | - | NPPES |
| NONE ASSIGNED | Medicaid | NM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | C 4939 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sreelatha Mandadi, SLP 5100 Marna Lynn Ave Nw, Albuquerque, NM 87114-5701 Ph: (505) 898-0923 | Sreelatha Mandadi, SLP 5100 Marna Lynn Ave Nw, Albuquerque, NM 87114-5701 Ph: (505) 898-0923 |
News Archive
Bristol-Myers Squibb Company today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that Daklinza (daclatasvir), an investigational, potent pan-genotypic NS5A complex inhibitor (in vitro), be granted approval for use in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults.
The success of kidney transplant is dependent on the age and sex of both the donor and the recipient, according to research published today in the Journal of the American Society of Nephrology.
The Guardian features an interview with Moncef Slaoui, now chair of research and development at GlaxoSmithKline, who discusses his 23-year involvement in the research leading to the RTS,S malaria vaccine that has shown to halve the risk of malaria among African children.
The Department of Health and Human Services will make available $600 million in loans to help start these co-ops, which were authorized by the health law. Meanwhile, various regulations regarding the health law's coverage expansions are pending at the Office of Management and Budget.
The coronavirus disease (COVID-19) causes severe illness in people with underlying health conditions, such as heart disease, hypertension, lung illness, and diabetes. Now, scientists warn that viral infection may trigger the development of diabetes in healthy people.
› Verified 4 days ago
Elizabeth Y Kam, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7801 Candelaria Rd Ne, Sandia Hs, Albuquerque, NM 87110 Phone: 505-294-1511 | |
Ms. Brittney Amber Martinez, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10800 Comanche Rd Ne Apt 329, Albuquerque, NM 87111 Phone: 505-927-8291 Fax: 505-266-6306 | |
Breanna White, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9500 Montgomery Blvd Ne Ste 215, Albuquerque, NM 87111 Phone: 505-247-4224 | |
Tyler Brewer, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6811 Taylor Ranch Rd Nw, Albuquerque, NM 87120 Phone: 505-898-1492 | |
Leslie Guzman, SLP-CF Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 6400 Uptown Blvd Ne, Suite 360w, Albuquerque, NM 87110 Phone: 505-855-9805 Fax: 505-848-9468 | |
Samantha Vance, SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6400 Uptown Blvd Ne Ste 360, Albuquerque, NM 87110 Phone: 505-299-9010 | |
Marsha Grover, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 412 Alameda Blvd Nw, Alameda Es, Albuquerque, NM 87114 Phone: 505-898-0070 |